메뉴 건너뛰기
Arthritis and Rheumatology
Volumn 66, Issue 3, 2014, Pages 770-
Determining adherence to therapeutic regimens in patients with chronic illness: Comment on the article
Author keywords

[No Author keywords available]
Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE;
EID: 84896311026     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38243     Document Type: Letter
Times cited : (7)
References (5)
  • 1
    • 84878524281 scopus 로고    scopus 로고
    • Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: Consequences of low adherence
    • Waimann CA, Marengo MF, de Achaval S, Cox VL, Garcia-Gonzalez A, Reveille JD, et al. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum 2013;65:1421-9.
    • (2013) Arthritis Rheum , vol.65 , pp. 1421-1429
    • Waimann, C.A.1    Marengo, M.F.2    De Achaval, S.3    Cox, V.L.4    Garcia-Gonzalez, A.5    Reveille, J.D.6
  • 2
    • 33750302628 scopus 로고    scopus 로고
    • Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
    • Costedoat-Chalumeau N, Amoura Z, Hulot JS, Hammoud HA, Aymard G, Cacoub P, et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54:3284-90.
    • (2006) Arthritis Rheum , vol.54 , pp. 3284-3290
    • Costedoat-Chalumeau, N.1    Amoura, Z.2    Hulot, J.S.3    Hammoud, H.A.4    Aymard, G.5    Cacoub, P.6
  • 3
    • 84881322752 scopus 로고    scopus 로고
    • Hydroxychloroquine in systemic lupus erythematosus: Results of a French multicentre controlled trial (PLUS Study)
    • Costedoat-Chalumeau N, Galicier L, Aumaitre O, Frances C, Le Guern V, Liote F, et al. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis 2013;72:1786-92.
    • (2013) Ann Rheum Dis , vol.72 , pp. 1786-1792
    • Costedoat-Chalumeau, N.1    Galicier, L.2    Aumaitre, O.3    Frances, C.4    Le Guern, V.5    Liote, F.6
  • 4
    • 34249779535 scopus 로고    scopus 로고
    • Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment in systemic lupus erythematosus
    • Costedoat-Chalumeau N, Amoura Z, Hulot JS, Aymard G, Leroux G, Marra D, et al. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment in systemic lupus erythematosus. Ann Rheum Dis 2007;66:821-4.
    • (2007) Ann Rheum Dis , vol.66 , pp. 821-824
    • Costedoat-Chalumeau, N.1    Amoura, Z.2    Hulot, J.S.3    Aymard, G.4    Leroux, G.5    Marra, D.6
  • 5
    • 84855361805 scopus 로고    scopus 로고
    • Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus
    • Ting TV, Kudalkar D, Nelson S, Cortina S, Pendl J, Budhani S, et al. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol 2012;39:174-9.
    • (2012) J Rheumatol , vol.39 , pp. 174-179
    • Ting, T.V.1    Kudalkar, D.2    Nelson, S.3    Cortina, S.4    Pendl, J.5    Budhani, S.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.